These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2883249)

  • 21. Clinical relevance of immunological markers in Graves' disease.
    Mann K; Saller B; Hörmann R
    Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726
    [No Abstract]   [Full Text] [Related]  

  • 22. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
    McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
    Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism.
    Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1036-40. PubMed ID: 6137493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ; Bierwolf B; Kuhlmann E; Klugmann T; Dietel P; Fischer S
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):331-6. PubMed ID: 2896115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the change in serum TBII before and after subtotal thyroidectomy for hyperthyroidism.
    Hoshi T
    Fukushima J Med Sci; 1985 Jun; 31(1):1-16. PubMed ID: 2867960
    [No Abstract]   [Full Text] [Related]  

  • 27. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
    Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid-stimulating antibody (TSab) detected in sera of Graves' patients using human thyroid cell cultures.
    Toccafondi RS; Aterini S; Medici MA; Rotella CM; Tanini A; Zonefrati R
    Clin Exp Immunol; 1980 Jun; 40(3):532-9. PubMed ID: 6251989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
    Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
    Kasagi K; Tamai H; Morita T; Hidaka A; Hatabu H; Misaki T; Iida Y; Ishihara T; Ikekubo K; Kuma K
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell subsets and thyroid-stimulating antibodies in patients with Graves' disease in clinical remission.
    Bagnasco M; Macchia E; Ciprandi G; Caria M; Fenzi GF
    J Endocrinol Invest; 1986 Jun; 9(3):217-21. PubMed ID: 2876022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism.
    Miyauchi A; Amino N; Tamaki H; Kuma K
    Am J Med; 1988 Sep; 85(3):418-20. PubMed ID: 2901227
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenesis of hyperthyroidism.
    Chopra IJ; Solomon DH
    Annu Rev Med; 1983; 34():267-81. PubMed ID: 6134495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The implications of "thyroid-growth-immunoglobulins" (TGI) for the understanding of sporadic nontoxic nodular goitre.
    Doniach D; Chiovato L; Hanafusa T; Bottazzo GF
    Springer Semin Immunopathol; 1982; 5(4):433-46. PubMed ID: 6131546
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between thyroid adenylate cyclase-stimulating and thyrotropin-binding inhibitor immunoglobulins in Graves' disease.
    Chang TC; Chen FW; Chang CC; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1985 May; 84(5):579-85. PubMed ID: 2864384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.